Home › Cancro al seno › New Jersey › Newark
Studi clinici su Cancro al seno a Newark, NJ
18 studi su Cancro al seno cercano partecipanti presso sedi a Newark e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
In reclutamentoFase 3
- Summit Health, Florham Park · a 12 mi di distanza
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Morristown Medical Center, Morristown · a 17 mi di distanza
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
In reclutamentoFase 2
- Medical Oncology Hematology Associates, Newark
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
In reclutamentoFase 3
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Newark
- Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey), Livingston · a 9 mi di distanza
- Summit Medical Group PA, Florham Park · a 12 mi di distanza
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
In reclutamentoFase 1/2
- Summit Medical Group, Florham Park · a 12 mi di distanza
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
In reclutamentoFase 3
- Summit Medical Group, Florham Park · a 12 mi di distanza
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
In reclutamentoStudio osservazionale
- Summit Medical Group, Florham Park · a 12 mi di distanza
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
In reclutamentoFase 3
- Summit Medical Group, Florham Park · a 12 mi di distanza
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
In reclutamentoFase 3
- Newark Beth Israel Medical Center, Newark
- Cooperman Barnabas Medical Center, Livingston · a 9 mi di distanza
- Morristown Medical Center, Morristown · a 17 mi di distanza
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
In reclutamentoFase 2
- GSK Investigational Site, Morristown · a 17 mi di distanza
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
In reclutamentoFase 3
- Morristown Medical Center, Morristown · a 17 mi di distanza
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
In reclutamento
- Rutgers State University of New Jersey Medical School, Newark
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Morristown Medical Center, Morristown · a 17 mi di distanza
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
In reclutamento
- Summit Health, Florham Park · a 12 mi di distanza
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted
In reclutamentoFase 2
- RWJBarnabas Health - Newark Beth Israel Medical Center, Newark
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
In reclutamentoFase 1
- RWJBarnabas Health Clara Maas Medical Center, Belleville · a 4 mi di distanza
- Cooperman Barnabas Medical Center, Livingston · a 9 mi di distanza
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
In reclutamentoFase 4
- Cancer Center Initiative, Newark
- University Hospital, Newark
- RWJBarnabas Health Newark Beth Israel Medical Center, Newark
- e altri 2
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
In reclutamentoFase 3
- Morristown Medical Center, Morristown · a 17 mi di distanza
Studi su Cancro al seno in altre città
- New York City, NY134 studi
- Houston, TX126 studi
- Boston, MA111 studi
- Nashville, TN80 studi
- Los Angeles, CA72 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Durham, NC63 studi
- Queens, NY63 studi
- Chicago, IL58 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Altri studi a Newark
- Cancro del polmone non a piccole cellule14 studi
- Lesioni del midollo spinale13 studi
- Leucemia mieloide acuta12 studi
- Cancro metastatico10 studi
- Insufficienza cardiaca10 studi
- Cancro pancreatico9 studi
- Malattie cardiovascolari9 studi
- Melanoma8 studi
- Cancro ai polmoni7 studi
- Cancro (tutti i tipi)7 studi
- Malattia di Crohn7 studi
- Ictus6 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.